7705 — GL Sciences Income Statement
0.000.00%
Last trade - 00:00
- ¥28bn
- ¥35bn
- ¥39bn
- 74
- 81
- 79
- 94
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24,801 | 25,530 | 29,217 | 33,120 | 38,680 |
Cost of Revenue | |||||
Gross Profit | 8,756 | 8,514 | 9,780 | 11,230 | 13,410 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21,849 | 22,863 | 25,419 | 28,312 | 32,674 |
Operating Profit | 2,952 | 2,667 | 3,798 | 4,807 | 6,006 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,423 | 2,762 | 3,964 | 4,999 | 6,491 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,407 | 1,975 | 2,807 | 3,549 | 4,512 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,006 | 1,633 | 2,257 | 2,795 | 3,499 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,006 | 1,633 | 2,257 | 2,795 | 3,499 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 180 | 166 | 226 | 275 | 354 |
Dividends per Share | |||||
Special Dividends per Share |